- Rydex Biotechnology Fund
Rydex Funds
- US
- Health/Biotechnology
Summary
The fund seeks capital appreciation by investing in small-and-mid-size companies in the United States.
The investment process is designed to highlight companies that are involved in the biotechnology industry.
The process also includes companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services.
Then the research team combines a proprietary quantitative and qualitative methodology to identify investment opportunities.
The team utilizes screens based on price, liquidity, and tradability to evaluate potential investments.
Then the manager constructs a diversified portfolio of stocks More
Price
Last Close
$62.2 ( -1.95 )
52 Week HL
$107.87 - $60.62
Net Assets
$191 M
Expense Ratio
1.46 %
Sector Allocation
Nov 30, -0001Top 10 Holdings
Mar 10, 2021Company Name
- ABBVIE INC
- Amgen Inc
- Gilead Sciences
- Illumina Inc
- Vertex, Inc.
Holding
- 6.81
- 5.56
- 4.71
- 3.71
- 3.40
Company Name
- Regeneron Pharmaceuticals
- Moderna Inc
- Biogen Inc
- Corteva INC
- HORIZON THERAPEUTICS
- Total
Holding
- 3.31
- 3.26
- 3.25
- 2.98
- 2.44
- 39.43%
Manager
Name
Michael P. Byrum
Leadership
Single Manager
Tenure
2003
Advisor
Performance
YTD
-19 %
3 Year
-12.86%
5 Year
-0.38%
Best
96.24%
1999
Worst
-45.56%
2002
Returns +
Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | -8.3% | -1.6% | -14.6% | 18.5% | -0.1% | 12.4% | -22.5% | 13.9% | 6.9% | 18.3% | - |
| Q2 | -12.2% | 10.1% | 28.3% | -3.9% | 8.7% | 7.7% | 1% | 7.7% | 6.1% | 6% | - |
| Q3 | - | -3.2% | 0.5% | -8.9% | 7.1% | 8.4% | 13.2% | -19.4% | 5.4% | 16.3% | - |
| Q4 | - | -18.7% | 3.3% | 14.8% | -18.1% | -2.7% | -9.2% | 10.1% | 11.7% | 3% | - |
Returns +
Monthly
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -10.6% | -3.9% | 6.7% | -2.6% | -9.3% | - | - | - | - | - | - | - |
| 2021 | 5.3% | -2.2% | -4.4% | 4.3% | -3.4% | 9.2% | -1.6% | 3.8% | -5.2% | 0.3% | -4.4% | -15.2% |
+
Annual
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 29% | 16% | 29% | -6% | 19% | 8% | -1% | 14% | 29% | 0% |
Alpha
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RYOIX | -19% | -15% | 14% | - | -9% | 30% | -20% | 9% | 34% | - | 37% |
| S&P 500 | - | 29% | 16% | 29% | -6% | 19% | 8% | -1% | 14% | 29% | - |
| Alpha | -19% | -43% | -2% | - | -3% | 11% | -28% | 9% | 20% | - | 37% |